Myeloid Neoplasms (AML/MDS)
1 clinical trials · Condition
◉ Watch Myeloid Neoplasms (AML/MDS)
| Record | Firm | Date |
|---|---|---|
| A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation (NCT05877599) | AstraZeneca | 2023-07-12 |
Track Myeloid Neoplasms (AML/MDS) automatically
Every clearance here is in the API, with alerts when new ones post.